Titre : Cervelet

Cervelet : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cervelet : Questions médicales les plus fréquentes", "headline": "Cervelet : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cervelet : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-08", "dateModified": "2025-04-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cervelet" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Métencéphale", "url": "https://questionsmedicales.fr/mesh/D020540", "about": { "@type": "MedicalCondition", "name": "Métencéphale", "code": { "@type": "MedicalCode", "code": "D020540", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.132.810.428" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cortex cérébelleux", "alternateName": "Cerebellar Cortex", "url": "https://questionsmedicales.fr/mesh/D002525", "about": { "@type": "MedicalCondition", "name": "Cortex cérébelleux", "code": { "@type": "MedicalCode", "code": "D002525", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.132.810.428.200.212" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vermis cérébelleux", "alternateName": "Cerebellar Vermis", "url": "https://questionsmedicales.fr/mesh/D065814", "about": { "@type": "MedicalCondition", "name": "Vermis cérébelleux", "code": { "@type": "MedicalCode", "code": "D065814", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.132.810.428.200.212.299" } } } ] }, { "@type": "MedicalWebPage", "name": "Noyaux du cervelet", "alternateName": "Cerebellar Nuclei", "url": "https://questionsmedicales.fr/mesh/D002529", "about": { "@type": "MedicalCondition", "name": "Noyaux du cervelet", "code": { "@type": "MedicalCode", "code": "D002529", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.132.810.428.200.337" } } }, { "@type": "MedicalWebPage", "name": "Angle pontocérébelleux", "alternateName": "Cerebellopontine Angle", "url": "https://questionsmedicales.fr/mesh/D002530", "about": { "@type": "MedicalCondition", "name": "Angle pontocérébelleux", "code": { "@type": "MedicalCode", "code": "D002530", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.132.810.428.200.462" } } } ], "about": { "@type": "MedicalCondition", "name": "Cervelet", "alternateName": "Cerebellum", "code": { "@type": "MedicalCode", "code": "D002531", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mario Manto", "url": "https://questionsmedicales.fr/author/Mario%20Manto", "affiliation": { "@type": "Organization", "name": "Unité Des Ataxies Cérébelleuses, CHU-Charleroi, Lodelinsart, Charleroi, Belgium. mario.manto@ulb.be." } }, { "@type": "Person", "name": "Michael Adamaszek", "url": "https://questionsmedicales.fr/author/Michael%20Adamaszek", "affiliation": { "@type": "Organization", "name": "Department of Clinical and Cognitive Neurorehabilitation, Klinik Bavaria Kreischa, Kreischa, Germany. michael.adamaszek@freenet.de." } }, { "@type": "Person", "name": "Hiroshi Mitoma", "url": "https://questionsmedicales.fr/author/Hiroshi%20Mitoma", "affiliation": { "@type": "Organization", "name": "Department of Medical Education, Tokyo Medical University, Tokyo 160-0023, Japan." } }, { "@type": "Person", "name": "Frank Van Overwalle", "url": "https://questionsmedicales.fr/author/Frank%20Van%20Overwalle", "affiliation": { "@type": "Organization", "name": "Faculty of Psychology and Center for Neuroscience, Vrije Universiteit Brussel, 1050, Brussels, Belgium." } }, { "@type": "Person", "name": "Jeremy D Schmahmann", "url": "https://questionsmedicales.fr/author/Jeremy%20D%20Schmahmann", "affiliation": { "@type": "Organization", "name": "Ataxia Unit, Cognitive Behavioral Neurology Unit, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 100 Cambridge Street, Suite 2000, Boston, MA 02114, United States. Electronic address: jschmahmann@mgh.harvard.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer.", "datePublished": "2023-04-29", "url": "https://questionsmedicales.fr/article/37120458", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10549-023-06943-x" } }, { "@type": "ScholarlyArticle", "name": "Influence of adverse effects of neoadjuvant chemoradiotherapy on the prognosis of patients with early-stage esophageal cancer (cT1b-cT2N0M0) based on the SEER database.", "datePublished": "2023-04-17", "url": "https://questionsmedicales.fr/article/37143768", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fsurg.2023.1131385" } }, { "@type": "ScholarlyArticle", "name": "Modified FOLFIRINOX (mFOLFIRINOX) as neoadjuvant therapy and 'salvage' in patients with high risk locally advanced rectal cancers - tolerance and early outcomes.", "datePublished": "2023-04-07", "url": "https://questionsmedicales.fr/article/38554321", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4103/jcrt.jcrt_225_22" } }, { "@type": "ScholarlyArticle", "name": "The role of diffusion magnetic resonance imaging in determining tumor aggressiveness during preoperative surgical planning in early-stage endometrial cancer.", "datePublished": "2023-04-04", "url": "https://questionsmedicales.fr/article/37014376", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00117-023-01134-7" } }, { "@type": "ScholarlyArticle", "name": "Survival and prognostic factors of early-stage non-small cell lung cancer in Central and Eastern Europe: A prospective cohort study.", "datePublished": "2023-03-23", "url": "https://questionsmedicales.fr/article/36952375", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.5791" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Système nerveux", "item": "https://questionsmedicales.fr/mesh/D009420" }, { "@type": "ListItem", "position": 3, "name": "Système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002490" }, { "@type": "ListItem", "position": 4, "name": "Encéphale", "item": "https://questionsmedicales.fr/mesh/D001921" }, { "@type": "ListItem", "position": 5, "name": "Tronc cérébral", "item": "https://questionsmedicales.fr/mesh/D001933" }, { "@type": "ListItem", "position": 6, "name": "Rhombencéphale", "item": "https://questionsmedicales.fr/mesh/D012249" }, { "@type": "ListItem", "position": 7, "name": "Métencéphale", "item": "https://questionsmedicales.fr/mesh/D020540" }, { "@type": "ListItem", "position": 8, "name": "Cervelet", "item": "https://questionsmedicales.fr/mesh/D002531" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cervelet - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cervelet", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cervelet", "description": "Comment diagnostiquer une dysfonction du cervelet ?\nQuels tests d'imagerie sont utilisés pour le cervelet ?\nQuels signes cliniques indiquent une atteinte du cervelet ?\nLe cervelet peut-il être affecté par des maladies génétiques ?\nComment évaluer l'équilibre d'un patient ?", "url": "https://questionsmedicales.fr/mesh/D002531?mesh_terms=Early+Detection+of+Cancer&page=998#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cervelet", "description": "Quels sont les symptômes d'une lésion cérébelleuse ?\nComment se manifeste l'ataxie cérébelleuse ?\nLes troubles de la parole sont-ils liés au cervelet ?\nQu'est-ce que le tremblement intentionnel ?\nLes vertiges peuvent-ils être causés par des problèmes au cervelet ?", "url": "https://questionsmedicales.fr/mesh/D002531?mesh_terms=Early+Detection+of+Cancer&page=998#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cervelet", "description": "Comment prévenir les troubles du cervelet ?\nLes accidents peuvent-ils affecter le cervelet ?\nY a-t-il des vaccins pour prévenir les infections cérébelleuses ?\nL'alcool peut-il nuire au cervelet ?\nComment éviter les maladies génétiques affectant le cervelet ?", "url": "https://questionsmedicales.fr/mesh/D002531?mesh_terms=Early+Detection+of+Cancer&page=998#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cervelet", "description": "Quels traitements existent pour les troubles du cervelet ?\nLa chirurgie est-elle une option pour les tumeurs cérébelleuses ?\nLes médicaments peuvent-ils aider les symptômes cérébelleux ?\nComment la rééducation aide-t-elle les patients cérébelleux ?\nLes thérapies alternatives sont-elles efficaces pour le cervelet ?", "url": "https://questionsmedicales.fr/mesh/D002531?mesh_terms=Early+Detection+of+Cancer&page=998#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cervelet", "description": "Quelles complications peuvent survenir après une lésion cérébelleuse ?\nLes troubles du cervelet peuvent-ils affecter la vie quotidienne ?\nLes patients cérébelleux risquent-ils des chutes ?\nLes troubles cognitifs peuvent-ils être liés au cervelet ?\nLes complications peuvent-elles être réversibles ?", "url": "https://questionsmedicales.fr/mesh/D002531?mesh_terms=Early+Detection+of+Cancer&page=998#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cervelet", "description": "Quels sont les facteurs de risque pour les troubles du cervelet ?\nL'âge influence-t-il les troubles du cervelet ?\nLes maladies auto-immunes affectent-elles le cervelet ?\nLe stress peut-il affecter le cervelet ?\nLes infections peuvent-elles endommager le cervelet ?", "url": "https://questionsmedicales.fr/mesh/D002531?mesh_terms=Early+Detection+of+Cancer&page=998#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction du cervelet ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un examen neurologique, des tests d'équilibre et des imageries cérébrales sont utilisés." } }, { "@type": "Question", "name": "Quels tests d'imagerie sont utilisés pour le cervelet ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM et le scanner sont couramment utilisés pour visualiser le cervelet." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une atteinte du cervelet ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de l'équilibre, des mouvements saccadés et des difficultés de coordination." } }, { "@type": "Question", "name": "Le cervelet peut-il être affecté par des maladies génétiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines ataxies héréditaires affectent le cervelet et sa fonction." } }, { "@type": "Question", "name": "Comment évaluer l'équilibre d'un patient ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme le Romberg et le test de marche sur ligne droite sont utilisés." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une lésion cérébelleuse ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Ataxie, tremblements, vertiges et troubles de la parole peuvent survenir." } }, { "@type": "Question", "name": "Comment se manifeste l'ataxie cérébelleuse ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des mouvements désordonnés et une perte d'équilibre." } }, { "@type": "Question", "name": "Les troubles de la parole sont-ils liés au cervelet ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des difficultés d'élocution peuvent résulter d'une dysfonction cérébelleuse." } }, { "@type": "Question", "name": "Qu'est-ce que le tremblement intentionnel ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "C'est un tremblement qui se produit lors de mouvements volontaires, souvent lié au cervelet." } }, { "@type": "Question", "name": "Les vertiges peuvent-ils être causés par des problèmes au cervelet ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cérébelleux peuvent entraîner des sensations de vertige." } }, { "@type": "Question", "name": "Comment prévenir les troubles du cervelet ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, l'exercice régulier et l'évitement des toxines peuvent aider." } }, { "@type": "Question", "name": "Les accidents peuvent-ils affecter le cervelet ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traumatismes crâniens peuvent causer des lésions au cervelet." } }, { "@type": "Question", "name": "Y a-t-il des vaccins pour prévenir les infections cérébelleuses ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins contre certaines infections comme la méningite peuvent aider à prévenir." } }, { "@type": "Question", "name": "L'alcool peut-il nuire au cervelet ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consommation excessive d'alcool peut entraîner des dommages au cervelet." } }, { "@type": "Question", "name": "Comment éviter les maladies génétiques affectant le cervelet ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Le conseil génétique peut aider à évaluer les risques pour les familles concernées." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles du cervelet ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "La rééducation, la thérapie physique et parfois des médicaments sont utilisés." } }, { "@type": "Question", "name": "La chirurgie est-elle une option pour les tumeurs cérébelleuses ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la chirurgie peut être nécessaire pour retirer des tumeurs au cervelet." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider les symptômes cérébelleux ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent soulager les symptômes, mais ne guérissent pas la cause." } }, { "@type": "Question", "name": "Comment la rééducation aide-t-elle les patients cérébelleux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elle améliore la coordination, l'équilibre et la fonction motrice par des exercices ciblés." } }, { "@type": "Question", "name": "Les thérapies alternatives sont-elles efficaces pour le cervelet ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines thérapies comme l'acupuncture peuvent aider, mais les preuves sont limitées." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une lésion cérébelleuse ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de l'équilibre, des chutes fréquentes et des difficultés de coordination." } }, { "@type": "Question", "name": "Les troubles du cervelet peuvent-ils affecter la vie quotidienne ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent rendre les activités quotidiennes difficiles, comme marcher ou écrire." } }, { "@type": "Question", "name": "Les patients cérébelleux risquent-ils des chutes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en raison de l'instabilité et des problèmes d'équilibre, le risque de chutes augmente." } }, { "@type": "Question", "name": "Les troubles cognitifs peuvent-ils être liés au cervelet ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines dysfonctions cérébelleuses peuvent entraîner des troubles cognitifs." } }, { "@type": "Question", "name": "Les complications peuvent-elles être réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent s'améliorer avec un traitement approprié et une rééducation." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles du cervelet ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, l'alcoolisme et les traumatismes crâniens sont des facteurs de risque." } }, { "@type": "Question", "name": "L'âge influence-t-il les troubles du cervelet ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de troubles cérébelleux augmente avec l'âge en raison de la dégénérescence." } }, { "@type": "Question", "name": "Les maladies auto-immunes affectent-elles le cervelet ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies auto-immunes peuvent provoquer des inflammations cérébelleuses." } }, { "@type": "Question", "name": "Le stress peut-il affecter le cervelet ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut exacerber les symptômes des troubles cérébelleux." } }, { "@type": "Question", "name": "Les infections peuvent-elles endommager le cervelet ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections virales ou bactériennes peuvent causer des lésions cérébelleuses." } } ] } ] }

Sources (10000 au total)

The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer.

There are a paucity of data and a pressing need to evaluate response to neoadjuvant chemotherapy (NACT) and determine long-term outcomes in young Black women with early-stage breast cancer (EBC).... We analyzed data from 2196 Black and White women with EBC treated at the University of Chicago over the last 2 decades. Patients were divided into groups based on race and age at diagnosis: Black wome... Young Black women had the highest risk of recurrence, which was 22% higher than young White women (p = 0.434) and 76% higher than older Black women (p = 0.008). These age/racial differences in recurre... Black women with EBC had significantly worse outcomes compared to White women in our cohort study. There is an urgent need to understand the disparities in outcomes between Black and White breast canc...

Influence of adverse effects of neoadjuvant chemoradiotherapy on the prognosis of patients with early-stage esophageal cancer (cT1b-cT2N0M0) based on the SEER database.

To analyze the prognostic impact of neoadjuvant chemoradiotherapy (NCRT) on early-stage (cT1b-cT2N0M0) esophageal cancer (ESCA) and construct a prognostic nomogram for these patients.... We extracted the clinical data about patients diagnosed with early-stage esophageal cancer from the 2004-2015 period of the Surveillance, Epidemiology, and End Results (SEER) database. We applied the ... Among patients who met the inclusion criteria, patients in the NCRT plus esophagectomy (ES) group had a poorer prognosis for overall survival (OS) and esophageal cancer-specific survival (ECSS) than p... Patients with early-stage ESCA (cT1b-cT2) did not benefit from NCRT, and we established a prognostic nomogram to provide clinical decision aid for the treatment of patients with early-stage ESCA....

Modified FOLFIRINOX (mFOLFIRINOX) as neoadjuvant therapy and 'salvage' in patients with high risk locally advanced rectal cancers - tolerance and early outcomes.

There is limited data with regard to the use of modified 5-fluoroural-leucovorin-irinotecan-oxaliplatin (mFOLFIRINOX) in terms of tolerance and enabling total mesorectal excision (TME) of locally adva... Patients with LARC from January 2018 to December 2020 receiving mFOLFIRINOX post NACTRT/SCRT to facilitate TME were evaluated. The primary endpoint was assessment of grade 3 and grade 4 treatment rela... Forty-seven patients were evaluated with a median age of 33 years (Range:18-59), 45% T4b status, 96% radiological circumferential margin (CRM) involved (79% CRM positive post NACTRT/SCRT), 43% extramu... Locally advanced rectal cancers with high-risk characteristics are a niche group of cancers with less-than-optimal outcomes post standard neoadjuvant strategies. mFOLFIRINOX appears to be well tolerat...

The role of diffusion magnetic resonance imaging in determining tumor aggressiveness during preoperative surgical planning in early-stage endometrial cancer.

The present study aimed to evaluate the relationship between tumor volume and apparent diffusion coefficient (ADC) in preoperative magnetic resonance imaging and deep myometrial invasion, tumor grade,... The study included 73 patients diagnosed with early-stage endometrial cancer based on histopathological examination between May 2014 and July 2019. Receiver operating characteristic (ROC) curve analys... The areas under the ROC curves (AUCs) of ADC and tumor volume in predicting LVI, DMI, and high tumor grade were significantly greater than those for superficial myometrial invasion and low-grade tumor... In the absence of pathological pelvic lymph nodes in early-stage endometrial cancer, tumor volume in DWI sequences determines the active tumor load and tumor aggressiveness. Furthermore, a low ADC ind...

Survival and prognostic factors of early-stage non-small cell lung cancer in Central and Eastern Europe: A prospective cohort study.

Although early diagnosis and surgical resection of the tumor have been shown to be the most important predictors of lung cancer survival, long-term survival for surgically-resected early-stage lung ca... In this prospective study we aimed to investigate the survival and prognostic factors of surgically-resected early-stage non-small cell lung cancer (NSCLC) in Central and Eastern Europe.... We recruited 2052 patients with stage I-IIIA NSCLC from 9 centers in Russia, Poland, Serbia, Czech Republic, and Romania, between 2007-2016 and followed them annually through 2020.... During follow-up, there were 1121 deaths (including 730 cancer-specific deaths). Median survival time was 4.9 years, and the 5-year overall survival was 49.5%. In the multivariable model, mortality wa... This study shows that the 5-year survival rate of surgically-resected stage I-IIIA NSCLC is still around 50% in Central and Eastern Europe. In addition to non-modifiable prognostic factors, lifetime p...

Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment.

Currently, targeting immune checkpoint molecules holds great promise for triple-negative breast cancer (TNBC). However, the expression landscape of immune checkpoint genes (ICGs) in TNBC remains large... Herein, we systematically investigated the ICGs expression patterns in 422 TNBC samples. We evaluated the ICGs molecular typing based on the ICGs expression profile and explored the associations betwe... Two ICGs clusters and two ICGs-related gene clusters were determined, which were involved in different survival outcomes, biological roles and infiltration levels of immune cells. We established a qua... Collectively, dissecting the ICGs expression patterns not only provides a new insight into TNBC subtypes but also deepens the understanding of ICGs in the tumor immune microenvironment....

Meta-analysis of laparoscopic radical hysterectomy, excluding robotic assisted versus open radical hysterectomy for early stage cervical cancer.

Recent evidence has shown an increase in recurrence and a decrease in overall survival in patients treated with laparoscopic radical hysterectomy (LRH) and robotic assisted radical hysterectomy (RRH) ...

Initial Experience With Trans-anal Minimally Invasive Surgery (TAMIS) for Rectal Polyps and Early Colorectal Cancers at Cumberland Infirmary, Carlisle.

Bowel cancer is the fourth most common type of cancer in the United Kingdom in 2019. Total mesorectal excision is the standard procedure for the removal of rectal tumors, however, it comes with seriou... During a five-year period, 42 patients underwent TAMIS at Cumberland Infirmary. The primary indication for TAMIS was distal rectal lesions, large rectal polyps up to 120 mm, and early rectal cancer (T... Our findings suggest that TAMIS produces positive results. The size of the lesions removed, and the effect of an early learning curve are reflected in the rate of specimen fragmentation and polyp recu...